Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one structure

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 

structure
  • CAS No:

    154447-36-6

  • Formula:

    C19H17NO3

  • Chemical Name:

    2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

  • Synonyms:

    4H-1-Benzopyran-4-one,2-(4-morpholinyl)-8-phenyl-;2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one;LY 294002;8-Phenyl-2-(morpholin-4-yl)-chromen-4-one;NSC 697286;SF 1101;2-Morpholin-4-yl-8-phenylchromen-4-one;2-Morpholino-8-phenyl-4H-chromen-4-one

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

LY294002 is a broad-spectrum inhibitor of PI3K with IC50s of 0.5, 0.57, and 0.97 μM for PI3Kα, PI3Kδ and PI3Kβ, respectively. It also inhibits CK2 with an IC50 of 98 nM.


LY294002 is a chromone substituted with a phenyl group at position 8 and a morpholine group at position 2. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, an autophagy inhibitor and a geroprotector. It is a member of chromones, a member of morpholines and an organochlorine compound.|Specific inhibitor of phosphatidylinositol 3-kinase.

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one Basic Attributes

343.8

307.34

1312995-182-4

31M2U1DVID

697286

DTXSID6042650

29349990

Characteristics

38.8

3.1

white to off-white solid

1.3±0.1 g/cm3

184 °C @ Solvent: Ethyl acetate

494.6°C at 760 mmHg

253.0±28.7 °C

1.627

soluble in DMSO at 5mg/ml. Insoluble in water

2-8°C

Safety Information

3

24-25

Drug Information

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one Use and Manufacturing

Methods of Manufacturing

(1) 2g of LY294002 and 0.15g of benzyl chloride were mixed and dissolved in acetonitrile;(2) adding 12 g of a compound having the structure shown in Formula VI to the above solution;(3) The solution obtained in step (2) is placed in a reaction flask and heated at 35 C. for 12 days.(4) After the completion of the reaction, the heating was stopped to room temperature, and an ice bath was used to obtain a precipitate as Compound 2(1) 2g LY294002 and0.1g of iodomethane was mixed and dissolved in n-propyl acetate;(2) adding 10 g of rapamycin to the above solution;(3) The solution obtained in step (2) is placed in a reaction flask and heated at 75 C. for 4 days.(4) After the reaction is completed, stop heating to room temperature, Wash with saturated saline solution, Drying under reduced pressure to give a powderThe substance is Compound 1.(1) 5g of LY294002 and 0.1g of benzyl chloride are mixed and dissolved in acetonitrile;(2) adding 10 g of a compound having the structure shown in Formula VII to the above solution;(3) The solution obtained in step (2) is placed in a reaction flask and heated at 90C for 24 hours;(4) After completion of the reaction, the heating was stopped to room temperature, and an ice bath was used to obtain a precipitate 3 as a compound.A solution of 2-morpholino-8-phenyl-4H-chromen-4-one (LY294002) (1.50 g, 4.93 mmol) and dichloromethyl methyl ether (15 mL) was stirred and heated to 80 C. for 2 hours under argon. The mixture was cooled to room temperature, and then concentrated in vacuo to give 4-chloro-2-morpholino-8-phenylchromenylium chloride (78) (2.06 g, 5.73 mmol).

Uses

LY294002 is a selective phosphatidylinositol 3-kinase (PI3K) inhibitor with a 2.7-fold greater potency than quercetin. LY294002 inhibits purified PI3K with an IC50 of 1.4 μM.

Computed Properties

Molecular Weight:307.3
XLogP3:3.1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:307.12084340
Monoisotopic Mass:307.12084340
Topological Polar Surface Area:38.8
Heavy Atom Count:23
Complexity:463
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.